It is well known that MAPKs play pivotal roles in carcinogenesis [17] and that the MAPK pathway is a key downstream signaling pathway regulated by epidermal growth factor receptor (EGFR) signaling in a number of cancers [14, 15]. The gene discussed is EGFR; the disease is cancer.